Prosapogenin CP4 and ursolic acid from Eriocapitella rivularis inhibit fluconazole-resistant Candida albicans

Wen-Biao Zu1, Zhao-Jie Wang1, Dong-Mei Tang1

  • 1Yunnan Characteristic Plant Extraction Laboratory, Key Laboratory of Medicinal Chemistry for Natural Resource, Ministry of Education and Yunnan Province, School of Chemical Science and Technology, Yunnan University, Kunming 650500, PR China.

Abstract

Insights

This study found that two compounds from Eriocapitella rivularis, prosapogenin CP4 and ursolic acid, show synergistic antifungal activity against Candida albicans, offering a new treatment for oral candidiasis.

Area of Science:

  • Mycology
  • Pharmacology
  • Natural Products Chemistry

Background:

  • Fungal diseases, including oral candidiasis (OC) caused by Candida albicans, affect over a billion people globally.
  • Eriocapitella rivularis is a traditional herb used to treat oral fungal infections.

Purpose of the Study:

  • To identify potent antifungal compounds from E. rivularis.
  • To elucidate the mechanisms of action of these compounds against C. albicans.

Main Methods:

  • Bio-guided isolation and network pharmacology identified anti-C. albicans compounds.
  • Antifungal, synergistic, and biofilm inhibition assays were performed.
  • In vivo efficacy was tested in a murine OC model.

Main Results:

  • Prosapogenin CP4 disrupted the fungal cell wall and plasma membrane, inhibited mitochondrial function, and affected hyphal growth.
  • Prosapogenin CP4 and ursolic acid showed synergistic activity against fluconazole-resistant C. albicans.
  • The combination inhibited biofilm formation, reduced fungal burden, and inflammation in vivo.

Conclusions:

  • A synergistic phytomedicine strategy using two triterpenoids from E. rivularis offers a promising therapeutic approach for OC.
  • This strategy is particularly effective for biofilm-associated oral candidiasis.

Related Concept Videos

Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to...
81
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
7.7K
Gene Regulation in Microbial Communities: Quorum Sensing01:28

Gene Regulation in Microbial Communities: Quorum Sensing

Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
912